AstraZeneca said on Friday it has agreed to a research deal with Chinese drugmaker CSPC Pharmaceuticals worth up to $5.22 billion to focus on AI-enabled initiatives.
(Reporting by Pushkala Aripaka in Bengaluru)
AstraZeneca said on Friday it has agreed to a research deal with Chinese drugmaker CSPC Pharmaceuticals worth up to $5.22 billion to focus on AI-enabled initiatives.
(Reporting by Pushkala Aripaka in Bengaluru)
Ocado Group will receive a one-off $350 million cash payment from Kroger as the U.S. grocer decided to close three...
WTI oil prices were heading for weekly gains of close to 2% in early trading on Friday, supported by an...
The Australian unit of U.S. oil giant Chevron Corp said on Friday that the partners of the Gorgon Joint Venture...
The U.S. dollar languished not far from a five-week low against its major peers on Friday as investors braced for...
British self-storage company Big Yellow Group said on Thursday that there was no basis of continuing discussions with Blackstone on...
Glenfarne's Alaska LNG unit said on Thursday it finalized an agreement to supply 1 million tonnes per annum of liquefied...